Correlation of the risk of breast cancer and disruption of the circadian rhythm (Review)

Oncology Reports

Volumn 28, Issue 2, 2012, Pages 418-428

  Leonardi, Giulia Costanza ^a   Rapisarda, Venerando ^a   Marconi, Andrea ^a   Scalisi, Aurora ^b   Catalano, Francesca ^c   Proietti, Lidia ^a   Travali, Salvo ^a   Libra, Massimo ^a   Fenga, Concettina ^d  

^a UNIVERSITY OF CATANIA   (Italy)

^b AUSL 3   (Italy)

^c CANNIZZARO HOSPITAL   (Italy)

^d UNIVERSITY OF MESSINA   (Italy)

Author keywords

Breast cancer; Cancer risk; Night work; Shift work

Indexed keywords

BREAST CANCER; BREAST CARCINOGENESIS; CANCER EPIDEMIOLOGY; CANCER RISK; CASE CONTROL STUDY; CIRCADIAN RHYTHM; CLINICAL FEATURE; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; HUMAN; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; OCCUPATIONAL EXPOSURE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SHIFT WORKER; SLEEP PATTERN;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; CIRCADIAN RHYTHM; COHORT STUDIES; FEMALE; HUMANS; RISK FACTORS;

EID: 84863494541     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1839     Document Type: Review

References (79)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005. (Pubitemid 40372904)
2. Bray F, McCarron P and Parkin DM: The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res 6: 229-239, 2004. (Pubitemid 39440251)
3. Althuis MD, Dozier JM, Anderson WF, Devesa SS and Brinton LA: Global trends in breast cancer incidence and mortality 1973-1997. Int J Epidemiol 34: 405-412, 2005. (Pubitemid 40645331)
4. Parkin DM and Fernandez LM: Use of statistics to assess the global burden of breast cancer. Breast J 12: 70-80, 2006.
5. Madigan MP, Ziegler RG, Benichou J, Byrne C and Hoover RN: Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst 87: 1681-1685, 1995.
6. Sacco AJ, Kaaks R and Little RE: Breast cancer: occurrence, risk factors and hormone metabolism. Expert Rev Anticancer Ther 3: 546-562, 2003. (Pubitemid 37009853)
7. Yager JD and Davidson NE: Estrogen carcinogenesis in breast cancer. N Engl J Med 354: 270-282, 2006.
8. Collaborative Group on Hormonal Factors in Breast Cancer: Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100239 women without breast cancer from 54 epidemiological studies. Lancet 347: 1713-1727, 1996.
9. Hamajima N, Hirose K, Tajima K, et al: Alcohol, tobacco and breast cancer - collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer 87: 1234-1245, 2002.
10. Krebs EE, Taylor BC, Cauley JA, Stone KL, Browman PJ and Ensrud KE: Measures of adiposity and risk of breast cancer in older postmenopausal women. J Am Geriatr Soc 54: 63-69, 2006.
11. Hsieh CC, Trichopoulos D, Katsouyanni K and Yuasa S: Age at menarche, age at menopause, height and obesity as risk factors for breast cancer: associations and interactions in an international case-control study. Int J Cancer 46: 796-800, 1990.
12. Straif K, Baan R, Grosse Y, Secretan B, Ghissassi FEL, Bouvard V, Altieri A, Benbrahim-Tallaa L and Cogliano V: Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol 8: 1065-1066, 2007.
13. Nagano M, Adachi A, Nakahama K, Nakamura T, Tamada M, Meyer-Bernstein E, Sehgal A and Shigeyoshi Y: An abrupt shift in the day/night cycle causes desynchrony in the mammalian circadian center. J Neurosci 23: 6141-6151, 2003. (Pubitemid 36859452)
14. Romon M, Nuttens MC, Fievet C, et al: Increased triglyceride levels in shift workers. Am J Med 93: 259-262, 1992.
15. Karlsson B, Knutson A and Lindhal B: Is there an association between shift work and having a metabolic syndrome? Results from a population based study of 27,485 people. Occup Environ Med 58: 747-752, 2001. (Pubitemid 33010493)
16. Morgan L, Hampton S, Gibbs M and Arendt J: Circadian aspects of postprandial metabolism. Chronobiol Int 20: 795-808, 2003. (Pubitemid 37187520)
17. Al-Naimi S, Hampton SM, Richard P, Tzung C and Morgan LM: Postprandial metabolic profiles following meals and snacks eaten during simulated night and day shift work. Chronobiol Int 21: 937-947, 2004. (Pubitemid 40019094)
18. Van Cauter E, Polonsky KS and Scheen AJ: Roles of circadian rhythmicity and sleep in human glucose regulation. Endocr Rev 18: 716-738, 1997. (Pubitemid 27435542)
19. Van Cauter E, Plat L and Copinschi G. Interrelations between sleep and somatotropic axis. Sleep 21: 553-566, 1998.
20. Hennig J, Kieferdorf P, Moritz C, Huwe S and Netter P: Changes in cortisol secretion during shift work: implications for tolerance to shift work. Ergonomics 41: 610-621, 1998. (Pubitemid 28211751)
21. Lac G and Chamoux A: Biological and psychological responses to two rapid shiftwork schedules. Ergonomics 47: 1339-1349, 2004. (Pubitemid 39365962)
22. Stevens RG: Electric power use and breast cancer: a hypothesis. Am J Epidemiol 125: 556-561, 1987.
23. Stevens RG: Artificial lighting in the industrialized world: circadian disruption and breast cancer. Cancer Causes Control 17: 501-507, 2006.
24. Megdal SP, Kroenke CH, Laden F, Pukkala E and Schernhammer ES: Night work and breast cancer risk: a systematic review and meta-analysis. Eur J Cancer 41: 2023-2032, 2005. (Pubitemid 41557687)
25. Kolstad HA: Nightshift work and risk of breast cancer and other cancers: a critical review of the epidemiologic evidence. Scand J Work Environ Health 34: 5-22, 2008.
26. Hansen J: Risk of breast cancer after night and shift work: current evidence and ongoing studies in Denmark. Cancer Causes Control 17: 531-537, 2006.
27. Schernhammer E and Schulmeister K: Light at night and cancer risk. Photochem Photobiol 79: 318-318, 2004.
28. Tynes T, Hannevik M, Andersen A, Vistnes AI and Haldorsen T: Incidence of breast cancer in Norwegian female radio and telegraph operators. Cancer Causes Control 7: 197-204, 1996. (Pubitemid 26155458)
29. Davis S, Mirick DK and Stevens RG: Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst 93: 1557-1562, 2001. (Pubitemid 32998485)
30. Hansen J: Increased breast cancer risk among women who work predominantly at night. Epidemiology 12: 74-77, 2001.
31. Lie JA, Roessink J and Kjaerheim K: Breast cancer and night work among Norwegian nurses. Cancer Causes Control 17: 39-44, 2006. (Pubitemid 43083668)
32. Hansen J and Stevens RG: Case-control study of shift-work and breast cancer risk in Danish nurses: impact of shift systems. Eur J Cancer: Aug 16, 2011 (Epub ahead of print).
33. Lie JA, Kjuus H, Zienolddiny S, Haugen A, Stevens RG and Kjærheim K: Night work and breast cancer risk among Norwegian nurses: assessment by different exposure metrics. Am J Epidemiol 173: 1272-1279, 2011.
34. O'Leary ES, Schoenfeld ER, Stevens RG, Kabat GC, Henderson K, Grimson R, Gammon MD and Leske MC: Shift work, light at night, and breast cancer on Long Island, New York. Am J Epidemiol 164: 358-366, 2006. (Pubitemid 44297344)
35. Pesch B, Harth V, Rabstein S, Baisch C, Schiffermann M, Pallapies D, Bonberg N, Heinze E, Spickenheuer A, Justenhoven C, et al: Night work and breast cancer: results from the German GENICA study. Scand J Work Environ Health 36: 134-141, 2010.
36. Hansen EJ: The distribution of living conditions. Main results from the welfare survey. Part I. Theory, method, and summary. Copenhagen, Teknisk Forlag, 1978.
37. Gammon MD, Neugut AI, Santella RM, Teitelbaum SL, Britton JA, Terry MB, Eng SM, Wolff MS, Stellman SD, Kabat GC, et al: The Long Island Breast Cancer Study Project: description of a multi-institutional collaboration to identify environmental risk factors for breast cancer. Breast Cancer Res Treat 74: 235-254, 2002. (Pubitemid 34848352)
38. Kjaer TK and Hansen J: Cancer incidence among a large cohort of female Danish registered nurses. Scand J Work Environ Health 35: 446-453, 2009.
39. Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I and Colditz GA: Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J Natl Cancer Inst 93: 1563-1568, 2001. (Pubitemid 32998486)
40. Schernhammer ES, Kroenke CH, Laden F and Hankinson SE: Night work and risk of breast cancer. Epidemiology 17: 108-111, 2006.
41. Schwartzbaum J, Ahlbom A and Feychting M: Cohort study of cancer risk among male and female shift workers. Scand J Work Environ Health 33: 336-343, 2007. (Pubitemid 350186761)
42. Pronk A, Ji BT, Shu XO, Xue S, Yang G, Li HL, Rothman N, Gao YT, Zheng W and Chow WH: Night-shift work and breast cancer risk in a cohort of Chinese women Am J Epidemiol 171: 953-959, 2010.
43. Stampfer MJ, Willett WC, Colditz GA, Rosner B, Speizer FE and Hennekens CH: A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med 313: 1044-1049, 1985. (Pubitemid 16243331)
44. Willett WC, Stampfer MJ, Colditz GA, Rosner BA, Hennekens CH and Speizer FE: Dietary fat and the risk of breast cancer. N Engl J Med 316: 22-28, 1987. (Pubitemid 17050165)
45. Stevens RG, Hansen J, Costa G, Haus E, Kauppinen T, Aronson KJ, Castaño-Vinyals G, Davis S, Frings-Dresen MH, Fritschi L, et al: Considerations of circadian impact for defining 'shift work' in cancer studies: IARC Working Group Report. Occup Environ Med 68: 154-162, 2011.
46. Klein K, Wegmann H, Athanassenas G, Hohlweck H and Kuklinski P: Air operations and circadian performance rhythms. Aviat Space Environ Med 47: 221-230, 1976.
47. Yamazaki S, Numano R, Abe M, Hida A, Takahashi R, Ueda M, Block GD, Sakaki Y, Menaker M and Tei H: Resetting central and peripheral circadian oscillators in transgenic rats. Science 288: 682-685, 2000. (Pubitemid 30241573)
48. Haus E and Smolensky M: Biological clocks and shift work: circadian dysregulation and potential long-term effects. Cancer Causes Control 17: 489-500, 2006.
49. Schibler U: Circadian time keeping: the daily ups and downs of genes, cells, and organisms. Prog Brain Res 153: 271-282, 2006.
50. Balsalobre A, Marcacci L and Schibler U: Multiple signaling pathways elicit circadian gene expression in cultured Rat-1 fibroblasts. Curr Biol 10: 1291-1294, 2000.
51. Yoo SH, Yamazaki S, Lowrey PL, Shimomura K, Ko CH, Buhr ED, Siepka SM, Hong HK, Oh WJ, Yoo OJ, et al: PERIOD2::LUCIFERASE real-time reporting of circadian dynamics reveals persistent circadian oscillations in mouse peripheral tissues. Poc Natl Acad Sci USA 101: 5339-5346, 2004. (Pubitemid 38481161)
52. Miller BH, McDearmon EL, Panda S, Hayes KR, Zhang J, Andrews JL, Antoch MP, Walker JR, Esser KA, Hogenesch JB and Takahashi JS: Circadian and CLOCK-controlled regulation of the mouse transcriptome and cell proliferation. Proc Natl Acad Sci USA 104: 3342-3347, 2007. (Pubitemid 46364161)
53. Reppert SM and Weaver DR: Coordination of circadian timing in mammals. Nature 418: 935-941, 2002. (Pubitemid 34976023)
54. Lowre PL and Takahashi JS: Mammalian circadian biology: elucidating genome-wide levels of temporal organization. Ann Rev Genomics Hum Genet 5: 407-441, 2004.
55. Panda S, Antoch MP, Miller BH, Su AI, Schook AB, Straume M, Schultz PG, Kay SA, Takahashi JS and Hogenesch JB: Coordinated transcription of key pathways in the mouse by the circadian clock. Cell 109: 307-320, 2002. (Pubitemid 34606874)
56. Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F and Okamura H: Control mechanism of the circadian clock for timing of cell division in vivo. Science 32: 255-259, 2003. (Pubitemid 37248750)
57. Fu L and Lee CC: The circadian clock: pacemaker and tumour suppressor. Nat Rev Cancer 3: 350-361, 2003. (Pubitemid 37328855)
58. Filipski E, Delaunay F, King VM, Wu MW, Claustrat B, Grechez-Cassiau A, Guettier C, Hastings MH and Francis L: Effects of chronic jet lag on tumor progression in mice. Cancer Res 64: 7879-7885, 2004. (Pubitemid 39446921)
59. Filipski E, King VM, Li X, Granda TG, Mormont MC, LiuX, Claustrat B, Hastings MH and Lévi F: Host circadian clock as a control point in tumor progression. J Natl Cancer Inst 94: 690-697, 2002. (Pubitemid 34552490)
60. Butcher GQ, Lee B, Hsieh F and Obrietan K: Light- and clock-dependent regulation of ribosomal S6 kinase activity in the suprachiasmatic nucleus. Eur J Neurosci 19: 907-915, 2004. (Pubitemid 38297028)
61. Ligresti G, Libra M, Militello L, Clementi S, Donia M, Imbesi R, Malaponte G, Cappellani A, McCubrey JA and Stivala F: Breast cancer: molecular basis and therapeutic strategies (Review). Mol Med Rep 1: 451-458, 2008.
62. Truchet I, Jozan S, Baron S, Frongia C, Balaguer P, Richard-Foy H and Valette A: Estrogen and antiestrogen-dependent regulation of breast cancer cell proliferation in multicellular spheroids: Influence of cell microenvironment. Int J Oncol 32: 1033-1039, 2008.
63. Echiburù-Chau C, Roy D and Calaf GM: Deleterious MnSOD signals lead to abnormal breast cell proliferation by radiation and estrogen exposure. Int J Oncol 38: 1703-1711, 2011.
64. Schernhammer ES, Rosner B, Willett WC, Laden F, Colditz GA and Hankinson SE: Epidemiology of urinary melatonin in women and its relation to other hormones and night work. Cancer Epidemiol Biomarkers Prev 13: 936-943, 2004. (Pubitemid 38756703)
65. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C and Mulvihill JJ: Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81: 1879-1886, 1989. (Pubitemid 20026073)
66. Nelson HD, Humphrey LL, Nygren P, Teutsch SM and Allan JD: Postmenopausal hormone replacement therapy: scientific review. JAMA 288: 872-881, 2002.
67. Blask DE, Sauer LA and Dauchy RT: Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy. Curr Top Med Chem 2: 113-132, 2002.
68. Blask DE, Dauchy RT, and Sauer LA: Putting cancer to sleep at night: the neuroendocrine/circadian melatonin signal. Endocrine 27: 179-188, 2005. (Pubitemid 41558450)
69. Reiter RJ: Mechanisms of cancer inhibition by melatonin. J Pineal Res 37: 213-214, 2004.
70. Baldwin WS and Barrett JC: Melatonin: receptor-mediated events that may affect breast and other steroid hormone-dependent cancers. Mol Carcinog 21: 149-155, 1998.
71. Collins A, Yuan L, Kiefer TL, Cheng Q, Lai L and Hill SM: Overexpression of the MT1 melatonin receptor in MCF-7 human breast cancer cells inhibits mammary tumor formation in nude mice. Cancer Lett 189: 49-57, 2003. (Pubitemid 35351519)
72. Blask DE and Hill SM: Effects of melatonin on cancer: studies on MCF-7 human breast cancer cells in culture. J Neural Transm Suppl 21: 433-449, 1986.
73. Cos S, Fernández R, Güézmes A and Sánchez- Barceló EJ: Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells. Cancer Res 58: 4383-4390, 1998. (Pubitemid 28450041)
74. Leon-Blanco MM, Guerrero JM, Reiter RJ, Calvo JR and Pozo D: Melatonin inhibits telomerase activity in the MCF-7 tumor cell line both in vivo and in vitro. J Pineal Res 35: 204-211, 2003. (Pubitemid 37100399)
75. Martínez-Campa C, Alonso-González C, Mediavilla MD, Cos S, González A, Ramos S and Sanchez-Barcelò EJ: Melatonin inhibits both ER alpha activation and breast cancer cell proliferation induced by a metalloestrogen, cadmium. J Pineal Res 40: 291-296, 2006.
76. Martínez-Campa C, Alonso-González C, Mediavilla MD, Cos S, González A, Ramos S and Sánchez-Barceló EJ: Melatonin down regulates hTERT expression induced by either natural estrogens (17b-estradiol) or metalloestrogens (cadmium) in MCF-7 human breast cancer cells. Cancer Lett 268: 272-277, 2008.
77. Molis TM, Spriggs LL, Jupiter Y and Hill SM: Melatonin modulation of estrogen-regulated proteins, growth factors, and proto-oncogenes in human breast cancer. J Pineal Res 18: 93-103, 1995.
78. Mediavilla MD, Güezmez A, Ramos S, Kothari L, Garijo F and Sánchez Barceló EJ: Effects of melatonin on mammary gland lesions in transgenic mice overexpressing N-ras protooncogene. J Pineal Res 22: 86-94, 1997. (Pubitemid 127731780)
79. Baturin DA, Alimova IN, Anisimov VN, Popovich IG, Zabezhinski MA, Provinciali M, Mancini R and Franceschi C: The effect of light regimen and melatonin on the development of spontaneous mammary tumors in HER-2/neu transgenic mice is related to a downregulation of HER-2/neu gene expression. Neuro Endocrinol Lett 22: 441-447, 2001. (Pubitemid 34026306)